SEDAR Interim Financial Statements

[
  {
    "companyName": "Neural Therapeutics Inc.",
    "reportingPeriodEnd": "2025-10-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": null,
    "incomeStatement": null,
    "cashFlowStatement": null,
    "investmentsAndOtherAssets": [
      {
        "type": "Investment in Associate",
        "description": "Investment in CWE European Holdings Inc. (30.61% equity interest acquired through Amalgamation A)",
        "ownershipPercentage": 30.61,
        "value": 1836339,
        "notes": "Recorded at $1,836,339 as at October 31, 2025. The Company records its share of income from the investment (income of $9,080 for the three months ended October 31, 2025)."
      }
    ],
    "shareStructure": {
      "authorizedShares": "unlimited",
      "issuedShares": 168700506,
      "classesOfShares": ["common shares"],
      "warrants": [
        {
          "number": 1282667,
          "exercisePrice": 0.05,
          "expiryDate": "2027-03-07"
        },
        {
          "number": 21357946,
          "exercisePrice": 0.05,
          "expiryDate": "2028-03-07"
        },
        {
          "number": 4999993,
          "exercisePrice": null,
          "expiryDate": "2026-02-03"
        },
        {
          "number": 575800,
          "exercisePrice": null,
          "expiryDate": "2026-02-03"
        }
      ],
      "options": [
        {
          "number": 725000,
          "exercisePrice": 0.05,
          "expiryDate": "2030-05-02"
        }
      ],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "2025-10-31": {
          "salaries": 0,
          "consultingFees": 51150,
          "bonus": 0,
          "total": 51150
        },
        "2024-10-31": {
          "salaries": 47115,
          "consultingFees": 29760,
          "bonus": 0,
          "total": 76875
        }
      },
      "namedIndividuals": [
        {
          "name": "Ian Campbell",
          "title": "CEO, Director",
          "period": "2025-10-31",
          "components": {
            "salary": 0,
            "bonus": 0,
            "total": 6000
          }
        },
        {
          "name": "John Durfy",
          "title": "Chairman of the Board",
          "period": "2025-10-31",
          "components": {
            "salary": 0,
            "bonus": 0,
            "total": 0
          }
        },
        {
          "name": "Alex Storcheus",
          "title": "Director",
          "period": "2025-10-31",
          "components": {
            "salary": 0,
            "bonus": 0,
            "total": 30000
          }
        }
      ],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "FMI Capital Advisory Inc.",
          "description": "Accounts payable for advisory services",
          "amount": 880,
          "period": "2025-10-31"
        },
        {
          "counterparty": "Marrelli Support Services Inc.",
          "description": "Accounts payable for accounting and CFO services",
          "amount": 21482,
          "period": "2025-10-31"
        },
        {
          "counterparty": "Alex Storcheus",
          "description": "Cash advanced to the Company for operating expenses and filing fees",
          "amount": 3558,
          "period": "2025-10-31"
        }
      ]
    },
    "subsequentEvents": []
  }
]